The adjuvanted RSV prefusion F protein-based vaccine RSVPreF3-AS01E Arexvy was first FDA approved for older adults in May ...

Even as the world is still grappling with the aftermath of the COVID-19 pandemic, a new virus has surfaced, causing scare ...

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity—primarily organ transplant ...

An eight-month-old infant in Bengaluru has tested positive for Human Metapneumovirus ( HMPV ), marking the first reported ...

Delhi health authorities have issued an advisory in response to rising cases of Human Metapneumovirus (HMPV) and other ...

It parallels earlier work done at the center to better understand how the immune systems of people who are immunocompromised respond to vaccines against SARS-CoV-2, the virus that causes COVID-19.

“We found that on average, older adults who are immunocompromised developed fewer antibodies against RSV following vaccination as compared with the very strong responses for healthy people over ...

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity — primarily organ ...

It parallels earlier work done at the center to better understand how the immune systems of people who are immunocompromised respond to vaccines against SARS-CoV-2, the virus that causes Covid-19. RSV ...

It parallels earlier work done at the center to better understand how the immune systems of people who are immunocompromised respond to vaccines against SARS-CoV-2, the virus that causes COVID-19.